ChemScene Thanksgiving Savings for Your Discovery 2026
Up to 90% off selected products for the U.S. market, November 1–30, 2026.
Deuterated Building Blocks: Small Changes, New Possibilities in Drug Discovery
🧪 Deuterated Building Blocks: Small Changes, New Possibilities in Drug Discovery
TRI-611: A Novel Turn-Helix Degron Interface for ALK Degradation
🔍 What caught our attention about TRI-611?
TRI-611: Molecular Glue Degradation of ALK-Driven Cancer Proteins
🧬 What if, instead of simply blocking a cancer protein, we could eliminate it altogether?
2026 Nobel Prize in Chemistry: Asymmetry, Non-Linear Effects and Autocatalysis
2026 Nobel Prize in Chemistry just celebrated two discoveries that changed how we think about asymmetry in chemistry.
ChemScene Is Hiring: US Sales and Technical Support Specialists
ChemScene Is Hiring: US Sales and Technical Support Specialists.
ChemScene Is Expanding Its Team in South Korea
ChemScene is expanding our team in South Korea!
Fluoroalkene Building Blocks for Metabolic Stability and Lead Optimization
Fluoroalkene Building Blocks for Metabolic Stability and Lead Optimization.
Three TLC Troubleshooting Tips for Clean, Reproducible Separations
🧪 Struggling with messy Thin Layer Chromatography (TLC) results?
Fluorinated CRBN Ligands for Next-Generation PROTACs
What if one tiny fluorine atom could supercharge your PROTAC? ⚛️
Unlocking Peptide Discovery with Unnatural Amino Acids
Unlocking Peptide Discovery with Unnatural Amino Acids.